Condition: Oncology · Sponsor: Charite University, Berlin, Germany
Using moderate whole-body hyperthermia (mWBH) in tumor patients to see the influence on circulating tumor cells, tumor response, quality of life, fatigue, psyche, immune response and tumor microenvironment
This description comes directly from the study's public registry record.
Sebastian Zschaeck, MD · 030450650764 · sebastian.zschaeck@charite.de
Julian Weingaertner, MD · 030450657057 · julian.weingaertner@charite.de
Always discuss trial participation with your own doctor first.
| Klinik für Radioonkologie und Strahlentherapie | Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05821166